Testing effectiveness (Phase 2)Study completedNCT02475278
What this trial is testing
Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine
Who this might be right for
NorovirusHealthy Participants
Takeda 50